As of 2025-08-08, the Fair Value of Mirati Therapeutics Inc (MRTX) is -51.74 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 58.70 USD, the upside of Mirati Therapeutics Inc is -188.14%.
With the market price of 58.70 USD and our fair value calculation, Mirati Therapeutics Inc (MRTX) is not a good investment. Investing in MRTX stocks now will result in a potential loss of 188.14%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -98.42 | -213.26 | -357.94 | -581.78 | -740.87 | -398.45 |
| YoY growth | -39.74% | -116.68% | -67.84% | -62.54% | -27.35% | -62.83% |
| Market Cap (mil) | 4,117.81 |
| P/E | |
| Forward P/E |
| EPS | -10.35 |
| Avg earnings growth rate | -62.83% |
| TTM earnings | -725.88 |